Biotech Values

[poorgradstudent]

Not until there is a large trial. I say that for 2 reasons:

1) Oncologists, by and large, do not change their treatment strategies based on small trials that are not widely used / accepted by the treatment community.

2) Nobody will be actively promoting this treatment strategy since it is a combination of agents, a couple of which are generics.

However, the results do look strong enough that it would be nice for a cooperative group to undertake a larger trial.